Singapore markets open in 7 hours 44 minutes
Straits Times Index
3,116.32 +14.39 (+0.46%) S&P 500
4,585.69 +47.26 (+1.04%) Dow
35,203.63 +623.55 (+1.80%) Nasdaq
15,148.75 +63.28 (+0.42%) BTC-USD
49,182.46 +498.82 (+1.02%) CMC Crypto 200
1,268.34 +8.18 (+0.65%)
Lonza Group Ltd (LZAGY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 11:35AM EST. Market open.
| Previous close | 78.13 |
| Open | 77.37 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 76.39 - 77.45 |
| 52-week range | 55.69 - 86.31 |
| Volume | |
| Avg. volume | 40,276 |
| Market cap | 56.931B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 73.85 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.33 (0.42%) |
| Ex-dividend date | 10 May 2021 |
| 1y target est | N/A |
- Business Wire
Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) ("Aurinia") and Lonza Ltd. (SIX: LONN) ("Lonza") today announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp, Switzerland. The dedicated facility (also referred to as "monoplant") will be equipped with state-of-the-art manufacturing equipment to provide cost and production efficiency for the manufacture of voclosporin, while expanding existing capacity and providing supply security to meet future commercial demand.
© 2021 Yahoo. All rights reserved.
